Mesenchymal stromal cell therapy: progress in manufacturing and assessments of potency

This publication has 107 references indexed in Scilit:

• Biodistribution of Mesenchymal Stem/Stromal Cells in a Preclinical Setting
  Stem Cells International, 2013
• Mesenchymal Stem Cells in Tissue Repair
  Frontiers in Immunology, 2013
• Immunological characteristics of human mesenchymal stem cells and multipotent adult progenitor cells
  Immunology & Cell Biology, 2013
• Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensing
  Cytotherapy, 2012
• Validation of the Microbiological Testing of Tissue Preparations Using the BACTEC^TMBlood Culture System
  Transfusion Medicine and Hemotherapy, 2012
• Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties
  Proceedings of the National Academy of Sciences, 2010
• Phenotypic Characterization of Distinct Human Bone Marrow–Derived MSC Subsets
  Annals of the New York Academy of Sciences, 2009
• Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement
  Cytotherapy, 2006
• The SH-3 and SH-4 Antibodies Recognize Distinct Epitopes on CD73 from Human Mesenchymal Stem Cells
  Biochemical and Biophysical Research Communications, 2001
• The Monoclonal Antibody SH-2, Raised against Human Mesenchymal Stem Cells, Recognizes an Epitope on Endoglin (CD105)
  Biochemical and Biophysical Research Communications, 1999